WHO Chief Warns Nipah Virus is ‘Rare but Serious’, Outbreak Confined to India

Key Takeaways:

• WHO Director-General Tedros confirms Nipah outbreak is currently restricted to India.
• Kerala has reported six cases, including two fatalities, since late August.
• There is no specific vaccine or treatment; care is supportive.
• WHO is aiding India with surveillance, containment, and research.

World Health Organization chief Tedros Adhanom Ghebreyesus has stated that while the Nipah virus is a rare disease, it poses a serious threat. He confirmed that cases linked to the current outbreak are confined to India.

“Nipah virus is a rare but serious disease. Cases linked to the outbreak are restricted to India. WHO is working with the government to support the response,” Tedros said in a post on X.

WHO’s Support for India’s Response

The global health body is actively supporting the Indian government, particularly in Kerala where the outbreak is centred. Assistance includes deploying technical staff and supplies.

“We are supporting the government with surveillance, infection prevention and control, clinical management, risk communication and community engagement,” he added.

“We are also working with partners to accelerate research and development for Nipah virus diagnostics, therapeutics and vaccines,” Tedros noted in a subsequent post.

Kerala’s Nipah Outbreak Status

The state of Kerala has recorded six laboratory-confirmed Nipah virus cases since August 30, resulting in two deaths. To curb transmission, the state government has established containment zones in several parts of Kozhikode district.

Understanding the Nipah Virus

Nipah is a zoonotic virus, meaning it can jump from animals (like fruit bats) to humans. Transmission can occur through contaminated food or direct contact with infected individuals.

Symptoms typically include:

• Fever and headache
• Cough, sore throat, and difficulty breathing
• Vomiting

In severe cases, the infection can lead to encephalitis—a dangerous inflammation of the brain—which can be fatal.

Currently, there is no approved specific antiviral treatment or vaccine for Nipah virus infection. Medical management focuses on providing supportive care to relieve symptoms and manage complications.